Niyati Bhagwati MD
Hematologic Oncology
Assistant Professor of Medicine. Attending Physician, Lincoln Medical and Mental Health Center.
Join to View Full Profile
300 North AveBattle Creek, MI 49017
Phone+1 269-245-8660
Fax+1 269-245-8639
Dr. Bhagwati is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1997
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1993 - 1995
Topiwala National Medical CollegeClass of 1991
Certifications & Licensure
MI State Medical License 2016 - 2027
NY State Medical License 2006 - 2027
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
Publications & Presentations
PubMed
- 7 citationsLenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.Roy S Herbst, Byoung Chul Cho, Caicun Zhou, Mauricio Burotto, Manuel Cobo Dols
Journal of Thoracic Oncology. 2025-09-01 - 98 citationsPhase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant,-Mutant, Metastatic Nonsquamous Non-Small ...James Chih-Hsin Yang, Dae Ho Lee, Jong-Seok Lee, Yun Fan, Filippo de Marinis
Journal of Clinical Oncology. 2024-12-01 - 34 citationsPembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Random...James Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, Jong-Seok Lee, Piotr Koralewski
Journal of Thoracic Oncology. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
